Leggett Thomas 4
4 · Black Diamond Therapeutics, Inc. · Filed Sep 16, 2020
Insider Transaction Report
Form 4
Leggett Thomas
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2020-09-14$10.86/sh+3,000$32,580→ 3,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-09-14−3,000→ 230,171 totalExercise: $10.86Exp: 2029-09-08→ Common Stock (3,000 underlying) - Sale
Common Stock
2020-09-14$31.00/sh−3,000$93,000→ 0 total
Footnotes (2)
- [F1]Shares sold pursuant to a pre-established 10b5-1 trading plan effective as of June 5, 2020.
- [F2]25% of the shares subject to this option vested and became exercisable on September 5, 2020, with the remainder vesting in 36 equal monthly installments thereafter.